Latest Isologic News

News, Insight, Education – Welcome to the Isologic Blog

9Jan, 2020


By |January 9th, 2020|Categories: Isologic News|0 Comments

Antimony Sulfide Colloid Tc99m injection January 9th, 2020 Dear Valued Customer, It is with great pleasure that we would like to inform you that Isologic has a new product within its portfolio. We are introducing Antimony Sulfide Colloid Tc99m injection. This product is indicated for use as [...]

5Dec, 2019

Gallium-68 generator, Galli Eo®

By |December 5th, 2019|Categories: Isologic News|0 Comments

IRE Elit and Isologic announce the approval of the Gallium-68 generator, Galli Eo®, as a drug in Canada   December 5th, 2019 - Fleurus, Belgium & Montreal, Canada: IRE ELIT, Belgian radiopharmaceutical company, has just received the Notice of Compliance (NOC) from Health Canada for its drug [...]

27Jun, 2019

I-131 Update June 27, 2019

By |June 27th, 2019|Categories: Isologic News|0 Comments

I-131 capsule and solution production update June 27th, 2019 Dear Valued Customer, We have been informed by our supplier that the last shipment of Sodium Iodide I-131 products (Therapeutics and Diagnostics) to the Canadian market will be June 26th and no production will occur until July 11th. Our [...]

12Jun, 2019

I-131 production update

By |June 12th, 2019|Categories: Isologic News|0 Comments

Iodine-131 Diagnostic and Therapeutic capsule production June 7th, 2019 Dear Customer, We would like to inform you that we received information from our vendor of I-131 that their supplier will be in maintenance for a period of 2 weeks starting June 17th. They are working closely with [...]

General Nuclear Medicine News

News and Education provided by World Leading Experts

1Mar, 2018

First diagnostic radiotracer for early diagnosis of Alzheimer’s disease approved in Canada

By |March 1st, 2018|Categories: In the press|0 Comments

PIRAMAL IMAGING SA AND ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ANNOUNCE COMMERCIAL APPROVAL OF NEURACEQ™ BY HEALTH CANADA MONTREAL, Feb. 28, 2017 /CNW Telbec Piramal Imaging SA and ISOLOGIC Innovative Radiopharmaceuticals today announce that Health Canada has issued a Notice of Compliance (NOC) to ISOLOGIC [...]

31Jan, 2018

IRE-ELiT S.A. & Isologic Sign Exclusive Agreement

By |January 31st, 2018|Categories: In the press|0 Comments

IRE-ELiT S.A. (Environment & Lifescience Technology) & Isologic signed an exclusive agreement for the distribution of Galli Eo™ 68Ge/ 68Ga generator in Canada FLEURUS, Belgium ; Montreal, Canada ; the 31st January. IRE-ELiT S.A. (Environment & Lifescience Technology) & Isologic Innovative Radiopharmaceuticals, the Canadian [...]

14Jan, 2016

ISOLOGIC Acquires Lantheus Canadian Imaging Centres

By |January 14th, 2016|Categories: In the press|0 Comments

ISOLOGIC Acquires Lantheus Canadian Imaging Centres ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ACQUIRES LANTHEUS MEDICAL IMAGING CANADIAN RADIOPHARMACEUTICAL CENTRES ISOLOGIC is pleased to announce the completion of an asset purchase agreement for the acquisition of the Canadian radiopharmacy and Gludef manufacturing and distribution [...]

4Jun, 2015

Piramal Announces Strategic Partnership with ISOLOGIC

By |June 4th, 2015|Categories: In the press|0 Comments

PIRAMAL IMAGING ANNOUNCES STRATEGIC PARTNERSHIP WITH ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS FOR EXCLUSIVE COMMERCIALIZATION OF NEURACEQ IN CANADA BOSTON, June 4, 2015 Piramal Imaging SA and ISOLOGIC Innovative Radiopharmaceuticals today announce the companies have entered into a strategic partnership and licensing agreement [...]

24Mar, 2014

Canadian Radiopharmacy Acquisitions

By |March 24th, 2014|Categories: In the press|0 Comments

PHARMALOGIC P.E.T. SERVICES OF MONTREAL COMPANY AND CARDINAL HEALTH CANADIAN RADIOPHARMACY ACQUISITIONS March 24th, 2014 IsoLogic is proud to announce that following the acquisitions of Pharmalogic P.E.T. Services of Montreal and Cardinal Health’s Ontario based radiopharmacies, it will operate the combined businesses as [...]